Those with concerns over the risks of suicide and suicidal thoughts and behaviors among young people who are given anti-depressant medications may be alarmed at recent news that the EMEA, or European Medicines Agency, has given its stamp of approval to prescriptions of Prozac for children eight years of age and older. The approval comes after the the British government asked Prozac’s manufacturer, Eli Lilly, to apply for the approval from the EMEA. Despite acknowledgment that some children will benefit from the move, opponents worry that long waiting lists for psychotherapy and a tendency to over-prescribe medications may result in negative consequences.
The preceding article was solely written by the author named above. Any views and opinions expressed are not necessarily shared by GoodTherapy.org. Questions or concerns about the preceding article can be directed to the author or posted as a comment below.
